Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Inflammatix
MedTech
Inflammatix collects FDA clearance for ER sepsis diagnostic test
In about 30 minutes, the benchtop TriVerity test aims to help ERs determine whether a patient is fighting off a bacterial or viral infection.
Conor Hale
Jan 21, 2025 11:30am
Inflammatix collects $57M as it awaits FDA review of sepsis test
Sep 12, 2024 11:30am
Inflammatix nets $102M to advance its rapid infection tests
Mar 16, 2021 7:00am
Inflammatix raises $32M for its point-of-care infection test
Jan 10, 2020 4:25pm